接受他莫昔芬治疗乳腺癌的子宫切除术后患者子宫内膜癌复发：病例报告。
Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report.
机构信息
Peninsula School of Medicine and Dentistry, Plymouth University, Plymouth PL6 8BU, UK.
Torbay and South Devon Foundation NHS Trust, Torquay TQ2 7AA, UK.
出版信息
J R Soc Med. 2020 Nov;113(11):454-456. doi: 10.1177/0141076820961087. Epub 2020 Oct 12.
Abstract
Tamoxifen exposure is a recognised risk for primary endometrial cancer. This case serves as a reminder to meticulously check the past medical history and inform patients of the risk-benefit of treatment as part of a shared-decision making process.
摘要
他莫昔芬暴露是原发性子宫内膜癌的已知风险。本病例提醒我们要仔细检查既往病史，并在共同决策过程中告知患者治疗的风险-获益。
相似文献
1
Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report.接受他莫昔芬治疗乳腺癌的子宫切除术后患者子宫内膜癌复发：病例报告。
J R Soc Med. 2020 Nov;113(11):454-456. doi: 10.1177/0141076820961087. Epub 2020 Oct 12.
2
Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.他莫昔芬治疗的无症状绝经后乳腺癌患者子宫内膜癌的检测：一例报告
J Med Assoc Thai. 2001 Jul;84(7):1033-6.
3
Gynaecological aspects of tamoxifen treatment in breast cancer patients.乳腺癌患者他莫昔芬治疗的妇科方面
Cancer Treat Rev. 1997 Sep-Nov;23(5-6):289-304. doi: 10.1016/s0305-7372(97)90029-3.
4
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71566-X.
5
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71567-1.
6
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):67-8. doi: 10.1016/s0140-6736(05)71565-8.
7
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):66-7. doi: 10.1016/S0140-6736(05)71563-4.
8
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(05)71561-0.
9
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(00)03579-0.
10
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):65-6; author reply 67. doi: 10.1016/S0140-6736(05)71562-2.
引用本文的文献
1
Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions.健康与疾病中的核受体：信号通路、生物学功能及药物干预
Signal Transduct Target Ther. 2025 Jul 28;10(1):228. doi: 10.1038/s41392-025-02270-3.
2
Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review.与乳腺癌和妇科癌症相关的常见多发性原发性癌症及其危险因素、发病机制、治疗和预后：综述
Front Oncol. 2022 Jun 8;12:840431. doi: 10.3389/fonc.2022.840431. eCollection 2022.
本文引用的文献
1
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.癌症特征、生物标志物与乳腺癌分子亚型
J Cancer. 2016 Jun 23;7(10):1281-94. doi: 10.7150/jca.13141. eCollection 2016.
2
Natural history of recurrences in endometrial carcinoma.子宫内膜癌复发的自然病程。
Oncol Lett. 2014 Oct;8(4):1800-1806. doi: 10.3892/ol.2014.2362. Epub 2014 Jul 18.
3
Factors predicting recurrent endometrial cancer.复发性子宫内膜癌的预测因素。
Facts Views Vis Obgyn. 2013;5(3):179-86.
4
Tamoxifen-induced endometrial carcinoma after a lag of 14 years.他莫昔芬诱发的子宫内膜癌，间隔14年后发病。
South Asian J Cancer. 2013 Jan;2(1):6. doi: 10.4103/2278-330X.105867.
5
Is time to recurrence after hysterectomy predictive of survival in patients with early stage endometrial carcinoma?子宫切除术后复发时间是否可预测早期子宫内膜癌患者的生存？
Gynecol Oncol. 2012 Oct;127(1):38-42. doi: 10.1016/j.ygyno.2012.06.042. Epub 2012 Jul 11.
6
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.乳腺癌治疗后子宫内膜癌的生存情况与他莫昔芬治疗的关系：三个国家的汇总结果。
Breast Cancer Res. 2012 Jun 12;14(3):R91. doi: 10.1186/bcr3206.
7
Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.他莫昔芬治疗乳腺癌期间子宫内膜增生的组织病理学行为。
Gynecol Oncol. 2006 May;101(2):269-73. doi: 10.1016/j.ygyno.2005.10.010. Epub 2005 Nov 17.
8
The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.子宫内膜增生的行为。对170例“未治疗”增生患者的长期研究。
Cancer. 1985 Jul 15;56(2):403-12. doi: 10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x.
Zotero 插件